Bringing G.H. Lofberg on board to run CVS Caremark's pharmacy benefit management propels the company toward its goal of launching what it calls pharmacogenomic clinical services next year. "We believe there will be a growing opportunity to tailor pharmaceutical treatment to patients based on genetic patterns," said CVS Caremark CEO Tom Ryan.

Related Summaries